MedTrace Logo

Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care (AtrialConnect)

NCT05893199 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2023-06-07

No results posted yet for this study

Summary

Atrial fibrillation (AF) is the most common cardiac arrhythmia in the world, with a large consumption of health resources. Telemedicine represents a new model of care, facilitating the individual approach to each patient and reducing costs and complications.

This is an an open-label, randomized, multicenter, clinical trial aiming to analyze the use of telemedicine with AF patients in real clinical practice at primary care in terms of efficacy, efficiency, patient perception and professional satisfaction.

The intervention will be based on the use of the Ti.Care app as the telemedicine support, in addition to the usual care. The follow-up will be carried out for 12 months.

Conditions

Interventions

DEVICE

Clinical monitoring using the Ti.Care app (https://ti.care/es)

Clinical monitoring using the Ti.Care app (https://ti.care/es)

OTHER

Usual care

usual follow-up in primary care both arms

Sponsors & Collaborators

  • Universidad Miguel Hernandez de Elche

    lead OTHER

Principal Investigators

  • Ariana Jordá Baldó, Medicine · Physician at Virgen del Puerto Hospital

  • Domingo L Orozco Beltrán, Medicine · Professor at Miguel Hernández University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-12-31
Completion
2025-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05893199 on ClinicalTrials.gov